Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules, including proteins, nucleic acids, lipids, and polysaccharides, undergo significant structural and functional changes in response to hypoxic conditions. This involves transcriptional reprogramming (primarily through HIFs), metabolic shifts towards glycolysis, altered protein synthesis rates, and modulation of cytoskeletal dynamics. These changes aim to promote cell survival and adaptation under low oxygen conditions but can also contribute to disease progression, especially in cancer and ischemia.
Various, depending on the specific macromolecule and drug. Examples include inhibiting HIF transcriptional activity, blocking glycolytic enzymes, or neutralizing ROS.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Macromolecules Under Hypoxic Conditions (N/A).